Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molidustat vs Epoetin for Anemia in CKD on Dialysis (DIALOGUE 4)
NCT01975818Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of molidustat in anemia of chronic kidney disease (CKD-A), sponsored by Bayer. Started Oct 2013; status: completed.
02
Drugs
molidustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01975818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975818.